11.03
Theravance Biopharma Inc 주식(TBPH)의 최신 뉴스
Theravance Biopharma Sets Q2 Earnings Date: Key Financial Results Coming August 12 After Market Close - Stock Titan
Applying Wyckoff theory to Theravance Biopharma Inc. stock Free Reliable Investment Entry Point Signals - Newser
How many analysts rate Theravance Biopharma Inc. as a “Buy”Achieve rapid returns with smart investment plans - jammulinksnews.com
What are analysts’ price targets for Theravance Biopharma Inc. in the next 12 monthsTrack high-yield stocks before they peak - jammulinksnews.com
What are the technical indicators suggesting about Theravance Biopharma Inc.Get expert analysis on top stock picks - jammulinksnews.com
Is Theravance Biopharma Inc. stock overvalued or undervaluedInvest confidently with data-driven strategies - jammulinksnews.com
What are the latest earnings results for Theravance Biopharma Inc.Consistent high-performance stocks - jammulinksnews.com
Moving Average Trends for Theravance Biopharma Inc. Stock: What They IndicateHigh Accuracy Alerts - Newser
Is Theravance Biopharma Inc. stock a good hedge against inflationFree Short-Term Stock Picks - Newser
Theravance Biopharma Inc. Stock Performance After Earnings: Historical InsightsFree VIP Investment Strategies - Newser
What makes Theravance Biopharma Inc. stock price move sharplyMinimized Risk Trading Plan - Newser
Why Theravance Biopharma Inc. stock attracts strong analyst attentionEntry Level Low Risk Picks - Newser
Theravance Biopharma Inc. Stock Analysis and ForecastOutstanding capital appreciation - PrintWeekIndia
Is Theravance Biopharma Inc. a good long term investmentFree Predictions - Autocar Professional
What analysts say about Theravance Biopharma Inc. stockExtraordinary earning power - PrintWeekIndia
Theravance Biopharma to Participate in an Upcoming Investor Conference - Citizen Tribune
Exclusive: Theravance Biopharma Leadership Reveals Strategic Updates at BTIG Conference Next Week - Stock Titan
What drives Theravance Biopharma Inc. stock priceConsistent triple-digit returns - jammulinksnews.com
How Theravance Biopharma Inc. stock performs during market volatilitySecure Your Capital Strategy - Newser
Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics - The Globe and Mail
Theravance Biopharma SVP Farnum sells $113,869 in stock By Investing.com - Investing.com Nigeria
Theravance Biopharma SVP Farnum sells $113,869 in stock - Investing.com India
5 Small Drug Stocks to Buy Amid Trump's New Tariff Threats - The Globe and Mail
자본화:
|
볼륨(24시간):